The FDA label for Wegovy reports nausea in approximately 44% of patients, while Ozempic has lower rates (around 15-20%)
Kimura T, Nakagawa K, Kubota H, Kojima Y, Goto Y, Yamagishi K,
Data on the primary outcome, the composite of all-cause mortality and HF-related hospitalization, was pooled using a random effect meta-analysis with additional subgroup analyses
The International Foundation of Employee Benefit Plans survey shows that roughly 30% of employers who currently cover the medication for weight loss say theyre considering restricting that coverage to control costs
Mounjaro (tirzepatide) and Ozempic (semaglutide) are in a class of drugs known as incretin mimetics
The device measures the amount of alcohol in a person's breath and provides an estimate of their current BAC level